Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    - Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).
    Difference
    13%
    Check dated 2025-10-05T10:12:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T03:16:00.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Updated the page to Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' control was removed, a minor UI change.
    Difference
    0.8%
    Check dated 2025-09-13T17:46:06.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-06T15:33:43.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, specifically mentioning Bristol-Myers Squibb, while removing references to Mirati Therapeutics Inc. and various location details.
    Difference
    10%
    Check dated 2025-08-30T12:14:45.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:53:31.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.